Paglicci, L.
Borgo, V.
Lanzarone, N.
Fabbiani, M.
Cassol, C.
Cusi, MG.
Valassina, M.
Scolletta, S.
Bargagli, E.
Marchetti, L.
Paladini, P.
Luzzi, L.
Fossi, A.
Bennett, D.
Montagnani, F. http://orcid.org/0000-0002-2267-1337
Funding for this research was provided by:
Università degli Studi di Siena
Article History
Received: 1 July 2020
Accepted: 6 January 2021
First Online: 21 January 2021
Compliance with ethical standards
:
: MF received speakers’ honoraria and support for travel to meetings from Bristol-Myers Squibb (BMS), Gilead, Janssen-Cilag, Merck Sharp & Dohme (MSD), ViiV Healtcare, and fees for attending advisory boards from BMS, Gilead and Janssen-Cilag. FM received support for travel to meetings from Angelini, she is the principal investigator in a study sponsored by TLS (Toscana Life Science) and by GSK Vaccine SRL and she is the contact person for a service contract between GSK Vaccine SRL and Department of Medical Biotechnologies, University of Siena, without receiving any personal remuneration. All the other authors have no conflicts to declare.
: The study was approved by the local ethics committee (Azienda Ospedaliera Universitaria Senese, protocol OSS_REOS n° 12908).